Don't miss out on Wednesday 6th November 2024, when Catalyst Pharmaceuticals (NASDAQ: CPRX) will disclose its third quarter financial results after market close. Investors will have the chance to learn more about the company's performance during the quarter.
Wall Street financial experts are forecasting that the company will announce an expected $0.30 profit per share for the quarter. Moreover, the firm is anticipated to disclose a total revenue of $123.42 million for this specific period.
In the corresponding quarter of the previous year, the company's earnings report revealed a per-share income of $0.49. This significant amount was attributed to the company's remarkable total revenue of $102.69 million generated during that specific period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $473.67 million. Additionally, they forecast the earnings per share to hit profit of $1.1 for the fiscal year.
The business has scheduled a conference call on 7th November 2024 at 08:30 AM eastern time to discuss Q3 financial results.
Catalyst Pharmaceuticals (CPRX) experienced a trading range of $21.68 to $22.20, along with a total volume of 921.40 thousand shares during the day. The stock concluded Friday's regular trading session at $21.89, showing an increase of 0.41 percent.
